Document is current
Any future updates will be listed below
-
Authors
Marshall, Karen M.
Wojciechowski, Jonathan P.
Jayawarna, Vineetha
Hasan, Abshar
Echalier, Cécile
Øvrebø, Øystein
Yang, Tao
Zhou, Kun
Kanczler, Janos M.
Mata, Alvaro
Salmeron-Sanchez, Manuel
Stevens, Molly M.
Oreffo, Richard O. C.
-
Funding
Funding for this research was provided by:
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
UK Regenerative Medicine Platform (MR/R015651/1)
ERC proof of concept (MINGRAFT)
ERC proof of concept (MINGRAFT)
National Institute for Health and Care Research (NIHR133314)
Biotechnology and Biological Sciences Research Council (BB/P017711/1)
- License Information
-
More Information
Article History
Received: 13 April 2024
Accepted: 3 October 2024
First Online: 28 October 2024
Declarations
:
: Stevens, M. M. reports financial support was provided by UK Regenerative Medicine Platform, and she invested in, consults for (or is on the scientific advisory boards or boards of directors) and conducts sponsored research funded by companies related to the biomaterials field. The remaining authors declare that they have no known competing financial interests or personal relationships that could have appeared to influence the work reported in this paper.
